Loss-of-function variants in UBAP1L cause autosomal recessive retinal degeneration.

Inherited retinal diseases UBAP1L Ubiquitin-Associated Protein 1-Like cone-rod dystrophy retinitis pigmentosa rod-cone dystrophy

Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
26 Feb 2024
Historique:
received: 12 09 2023
revised: 23 02 2024
accepted: 23 02 2024
medline: 29 2 2024
pubmed: 29 2 2024
entrez: 29 2 2024
Statut: aheadofprint

Résumé

Inherited retinal diseases (IRDs) are a group of monogenic conditions that can lead to progressive blindness. Their missing heritability is still considerable, due in part to the presence of disease genes that await molecular identification. The purpose of this work was to identify novel genetic associations with IRDs. Patients underwent a comprehensive ophthalmological evaluation using standard-of-care tests, such as detailed retinal imaging (macular OCT, short-wavelength fundus autofluorescence) and electrophysiological testing. Exome and genome sequencing, as well as computer-assisted data analysis were used for genotyping and detection of DNA variants. A minigene-driven splicing assay was performed to validate the deleterious effects of one of such variants. We identified 8 unrelated families from Hungary, the United States, Israel, and the Netherlands with members presenting with a form of autosomal recessive and nonsyndromic retinal degeneration, predominantly described as rod-cone dystrophy but also including cases of cone / cone-rod dystrophy. Age of disease onset was very variable, with some patients experiencing first symptoms during their fourth decade of life or later. Myopia greater than 5 diopters was present in 5 of 7 cases with available refractive data, and retinal detachment was reported in 2 cases. All ascertained patients carried biallelic loss-of-function variants in UBAP1L (HGNC: 40028), a gene with unknown function and with homologies to UBAP1, encoding a protein involved in ubiquitin metabolism. One of these pathogenic variants, the intronic NM_001163692.2:c.910-7G>A substitution, was identified in five unrelated families. Minigene-driven splicing assays in HEK293T cells confirmed that this DNA change is responsible for the creation of a new acceptor splice site, resulting in aberrant splicing. We identified UBAP1L as a novel IRD gene. Although its function is currently unknown, UBAP1L is almost exclusively expressed in photoreceptors and the retinal pigment epithelium, hence possibly explaining the link between pathogenic variants in this gene and an ocular phenotype.

Identifiants

pubmed: 38420906
pii: S1098-3600(24)00039-X
doi: 10.1016/j.gim.2024.101106
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101106

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Ji Hoon Han (JH)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Kim Rodenburg (K)

Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.

Tamar Hayman (T)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Giacomo Calzetti (G)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Karolina Kaminska (K)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Mathieu Quinodoz (M)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.

Molly Marra (M)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Sandrine Wallerich (S)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland.

Gilad Allon (G)

Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.

Zoltán Z Nagy (ZZ)

Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Krisztina Knézy (K)

Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Yumei Li (Y)

Department of Molecular and Human Genetics, Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Rui Chen (R)

Department of Molecular and Human Genetics, Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Mirella Telles Salgueiro Barboni (MTS)

Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Paul Yang (P)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Mark E Pennesi (ME)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

L Ingeborgh van den Born (LI)

The Rotterdam Eye Hospital, Rotterdam, the Netherlands.

Balázs Varsányi (B)

Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Viktória Szabó (V)

Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

Dror Sharon (D)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Eyal Banin (E)

Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

Tamar Ben-Yosef (T)

Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Susanne Roosing (S)

Department of Human Genetics, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.

Robert K Koenekoop (RK)

Departments of Pediatric Surgery, Human Genetics and Ophthalmology, Montreal Children's Hospital, McGill University and McGill University Health Center Research Institute, Montreal, Quebec, Canada.

Carlo Rivolta (C)

Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University Hospital Basel, Basel, Switzerland; Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom.

Classifications MeSH